IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Omega Fund Management, LLC

Portfolio Profile

CIK: 0001637359 | Boston, MA

Investment Profile

Style

GARP

Turnover

Low

Orientation

Concentrated trader
$185.7M
AUM
10
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Bicara Therapeutics Inc.(BCAX)1,822,150$54.1M29.14%
2Nuvation Bio Inc.(NUVB)8,081,089$45.9M24.72%
3Kestra Med Technologies Ltd(KMTS)1,022,149$26.0M14.00%
4BridgeBio Oncology Therapeutics Inc.(BBOT)3,289,661$25.1M13.50%
5Beta Bionics Inc.(BBNX)1,316,183$20.6M11.11%

Sector Allocation

Latest filing, equity positions only

Healthcare85.97% · $159.6M
Unclassified14.03% · $26.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare87.51%85.97%-1.54%
Unclassified12.49%14.03%+1.54%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$108.9M | 12 pos.
$123.4M | 14 pos.
$155.0M | 11 pos.
$135.0M | 11 pos.
$160.0M | 11 pos.
$33.5M | 1 pos.
6
Alumis Inc.(ALMS)
241,255
$6.8M
3.66%
7Sana Biotechnology, Inc.(SANA)843,750$2.9M1.59%
8ImageneBio, Inc.(IMA)455,361$2.7M1.45%
9enGene Holdings Inc.(ENGN)876,357$1.5M0.82%
10Odyssey Therapeutics Inc.(ODTX)2,893$54.1K0.03%
Cap SizePrev %Curr %Change
Small Cap82.86%80.86%-2%
Unclassified12.49%14.03%+1.54%
Mid Cap3.26%3.66%+0.4%
Micro Cap1.4%1.45%+0.05%
$169.5M | 13 pos.
$154.4M | 13 pos.
$222.4M | 12 pos.
$286.5M | 11 pos.
$163.1M | 10 pos.
$185.7M | 10 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
1
Closed
0
Increased
1
Decreased
8
Unchanged